Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease
about
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapiesMechanisms of hemorrhagic cystitis.Notch4 signaling pathway in a Kawasaki disease mouse model induced by Lactobacillus casei cell wall extract.Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.Endothelial Nlrp3 inflammasome activation associated with lysosomal destabilization during coronary arteritis.Effect of Nd:YAG laser-assisted non-surgical periodontal therapy on clinical periodontal and serum biomarkers in patients with and without coronary artery disease: A short-term pilot study.IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1βA child with resistant Kawasaki disease successfully treated with anakinra: a case report.Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki diseaseIntegrins α4 and αM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy.The NLRP3 rs10754558 Polymorphism Is Associated with the Occurrence and Prognosis of Coronary Artery Disease in the Chinese Han Population.GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency.Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm.GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease.Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).Quercetin Inhibits Inflammasome Activation by Interfering with ASC Oligomerization and Prevents Interleukin-1 Mediated Mouse Vasculitis.IL-1 Inhibition May Have an Important Role in Treating Refractory Kawasaki Disease.Management of acute and refractory Kawasaki disease.The role of the inflammasome in cardiovascular diseases.miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.Clinical features and correct diagnosis of macrophage activation syndrome.The Clinical Diagnosis and Management of Kawasaki Disease: a Review and Update.Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.Isoorientin attenuates lipopolysaccharide-induced pro-inflammatory responses through down-regulation of ROS-related MAPK/NF-κB signaling pathway in BV-2 microglia.Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease.Pro-inflammatory cytokine single nucleotide polymorphisms in Kawasaki disease.NOD1, a new player in cardiac function and calcium handling.In Utero Particulate Matter Exposure Produces Heart Failure, Electrical Remodeling, and Epigenetic Changes at Adulthood.Association of Toll-like receptor 2-positive monocytes with coronary artery lesions and treatment nonresponse in Kawasaki disease.Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.Adjunctive therapies in Kawasaki disease.CD8+ T Cells Contribute to the Development of Coronary Arteritis in the Lactobacillus casei Cell Wall Extract-Induced Murine Model of Kawasaki Disease.Treatment Options for Resistant Kawasaki Disease.Innate immune responses following Kawasaki disease and toxic shock syndrome.Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction.Adeno-associated Virus Vector-mediated Interleukin-10 Induction Prevents Vascular Inflammation in a Murine Model of Kawasaki Disease.Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease.Circulating adipokines are associated with Kawasaki disease.
P2860
Q26799747-271EE7AE-1401-4D9A-B0D9-08B52FC53D21Q27686784-105A16A2-2AA5-43DD-9095-440C11F696F6Q33744256-C1EBF384-1A25-483B-90C8-2B4B7FC1418CQ34377832-2D163A9E-7863-44E5-8240-093977C9767AQ34898750-4946F134-95C6-4436-847D-23ACD1FFD1E7Q35914827-714DC021-1432-4767-9291-C8419A0A9013Q36326783-36F7A99B-DB5B-442A-8DF3-8A5778857E3AQ36340938-95679409-F185-4BCE-8335-613A7B425C75Q36344968-5DC81438-ABBD-4E27-A8D6-43F311D891FBQ36416679-6AAB9721-F116-472A-9108-3C4E4847E295Q36677180-5374A6A6-D344-4359-BE05-26B00E7A807BQ36773481-EF3BEA53-8115-46CC-8C19-F06D59AB424EQ36793496-A899313A-0A6A-41A4-86DD-D454DF5071AFQ36849601-55EFA381-B715-491F-95D7-90A4B087CC9DQ37272083-97148B59-1D98-4167-990E-2C6C0AE202B3Q37572983-E5D77B4B-AC18-43A4-88BE-C15FC5145C66Q37620412-42778DBF-C276-4B1E-B3BD-5FD198E7E4C3Q37723505-E3DC5754-DB8E-4283-AA6B-F51B61F5D28DQ38063969-9616301E-A5FD-4B94-B70F-B63A58F7803EQ38196722-0EC0E2ED-ED45-4057-8778-729D090B3E5EQ38383813-F81F4D6D-6E2F-4B71-A159-34EE342EC3D6Q38530013-69DE1F0F-D851-4CA3-9E09-5CD93F18BCC3Q38967070-9501385B-16B3-4E75-A199-9B64B963E25DQ38993829-F90D6834-8F04-492B-9E07-C44192F0EE82Q39082239-1BD2F039-D599-4DC6-AB61-0D485BA617D7Q40402609-1FCB8321-FAD4-494A-9A79-2860D28DD565Q40600941-AED09BF0-54AF-49E9-B927-8E730F0538F6Q41138874-3355A48C-4B26-4115-8C9F-4F6D8AA38956Q41166374-6B1D594C-C1BD-4636-94A8-53949CF69790Q41537500-8F90CF83-F5CA-447D-B56A-90F67DF34BF0Q41862491-0552B34F-2118-4334-AD17-9F550BA7C3A4Q45978588-2AFDDA91-63E5-444B-8FE3-31D9651EDE5CQ46401492-357272A5-4024-47D1-BF2B-32B4253FABE2Q47660588-1C9809B3-15D9-4DA1-B89F-2A28B7E7143EQ49980459-B77EAF2E-38A3-4017-A2DF-AEAF2B9A5AF1Q52609376-315F9D6C-176D-4981-8905-BCBAA3A46297Q53681768-92FD0896-80E7-4C8F-99C0-D04A85C349D6Q54945663-1BE07F55-46E5-45C4-8015-34FBD5BA5178Q55282943-B5F3DF81-B04F-43F0-A92F-5F97D2B08661
P2860
Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Interleukin-1β is crucial for ...... ouse model of Kawasaki disease
@ast
Interleukin-1β is crucial for ...... ouse model of Kawasaki disease
@en
Interleukin-1β is crucial for ...... ouse model of Kawasaki disease
@nl
type
label
Interleukin-1β is crucial for ...... ouse model of Kawasaki disease
@ast
Interleukin-1β is crucial for ...... ouse model of Kawasaki disease
@en
Interleukin-1β is crucial for ...... ouse model of Kawasaki disease
@nl
prefLabel
Interleukin-1β is crucial for ...... ouse model of Kawasaki disease
@ast
Interleukin-1β is crucial for ...... ouse model of Kawasaki disease
@en
Interleukin-1β is crucial for ...... ouse model of Kawasaki disease
@nl
P2093
P2860
P3181
P1433
P1476
Interleukin-1β is crucial for ...... ouse model of Kawasaki disease
@en
P2093
Danica J Schulte
Kenichi Shimada
Michael C Fishbein
Norika Chiba
Shuang Chen
Thomas J A Lehman
Timothy R Crother
Youngho Lee
P2860
P304
P3181
P356
10.1161/CIRCULATIONAHA.111.072769
P407
P50
P577
2012-03-27T00:00:00Z